Craft
KIYATEC

KIYATEC

Total Funding

$10.4 M

KIYATEC Summary

Company summary

Overview
KIYATEC is a company specializing in oncology treatment. It uses ex vivo 3D cell culture technology platform to model and predict response to approved and investigational cancer drugs targeting a spectrum of solid tumors. The company also focuses on the validation of clinical assays as well as investigator-initiated studies in ovarian cancer, breast cancer, glioblastoma and rare tumors.
Type
Private
Founded
2005
HQ
Greenville, SC, US | view all locations
Website
http://kiyatec.com/
Cybersecurity rating
Sectors

Key people

  • Matthew R. Gevaert, CEO & Co-Founder, Director

    • Lillia M. Holmes, Chief Operations Officer

      • Tessa Desrochers, Chief Scientific Officer

        • Timothy Decker, VP Sales & Marketing

        LocationsView all

        1 location detected

        • Greenville, SC HQ

          United States

          900-B W Faris Rd

        Footer menu